In Oceania, drug production, trafficking and consumption remain overwhelmingly a criminal justice issue. However, Australia and New Zealand have moved towards policies that prioritise health to respond to drug use. More recently, New Zealand made the headlines with the adoption of an innovative policy towards new psychoactive substances.
This is the results of Australian Needle and Syringe Programs survey from 2009 to 2013, with annual sentinel surveillance of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibody prevalence and associated risk behaviours among PWID,
This paper provides an overview of what is known about medicinal cannabis use in Australia, the current state of the scientific and medical evidence for its use, and problems with the current situation in Australia.